Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Global Medical REIT (GMRE-PB) Depreciation & Amortization - Total (2016 - 2025)

Global Medical REIT (GMRE-PB) has disclosed Depreciation & Amortization - Total for 11 consecutive years, with $11.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization - Total rose 9.85% year-over-year to $11.2 million, compared with a TTM value of $44.0 million through Dec 2025, up 8.9%, and an annual FY2025 reading of $44.0 million, up 8.9% over the prior year.
  • Depreciation & Amortization - Total was $11.2 million for Q4 2025 at Global Medical REIT, roughly flat from $11.2 million in the prior quarter.
  • Across five years, Depreciation & Amortization - Total topped out at $11.3 million in Q2 2025 and bottomed at $7.8 million in Q1 2021.
  • Average Depreciation & Amortization - Total over 5 years is $10.0 million, with a median of $10.1 million recorded in 2022.
  • The sharpest move saw Depreciation & Amortization - Total skyrocketed 34.48% in 2021, then fell 3.63% in 2024.
  • Year by year, Depreciation & Amortization - Total stood at $9.0 million in 2021, then grew by 16.96% to $10.6 million in 2022, then decreased by 3.55% to $10.2 million in 2023, then fell by 0.1% to $10.2 million in 2024, then increased by 9.85% to $11.2 million in 2025.
  • Business Quant data shows Depreciation & Amortization - Total for GMRE-PB at $11.2 million in Q4 2025, $11.2 million in Q3 2025, and $11.3 million in Q2 2025.